Ra­di­oli­gands are go­ing on air: Ak­tis gains third Big Phar­ma backer

In­trigue in ra­di­oli­gands, or drugs made of ra­dioac­tive atoms at­tached to hom­ing pro­teins, has been grow­ing in the past few years, par­tic­u­lar­ly for treat­ing metasta­t­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER